Showing 61 - 80 of 142 results
A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.
By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee.
ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
About 70 representatives from business and industry groups, local business chambers, councils and the education sector from southern Sydney heard about ANSTO’s Innovation Precinct.
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.